A large proportion of human cancers carry mutations in PI3K pathway components, including loss of PTEN, and “activating” mutations in p110α (PIK3CA, these focus into hot-spots at H1047 and E545 [35]), p85α [36] and PKB [37], [38]. Here, AKT1 is linked to cancer.